Daxor Return on Investment 2010-2011 | DXR

Current and historical return on investment (ROI) values for Daxor (DXR) over the last 10 years.
Daxor ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2011-12-31 $-0.01B 0.00%
2011-09-30 $-0.01B 0.00%
2011-06-30 $-0.01B 0.00%
2011-03-31 $-0.01B 0.00%
2010-12-31 $-0.01B 0.00%
2010-09-30 $-0.01B 0.00%
2010-06-30 $-0.01B 0.00%
2010-03-31 $0.00B 0.00%
2009-12-31 $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.036B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.711B 19.42
Encompass Health (EHC) United States $11.842B 25.10
DaVita (DVA) United States $11.065B 14.69
Chemed (CHE) United States $8.448B 26.55
Elanco Animal Health (ELAN) United States $5.962B 12.78
Option Care Health (OPCH) United States $5.476B 24.41
RadNet (RDNT) United States $4.123B 87.25
Amedisys (AMED) United States $3.155B 21.22
LifeStance Health (LFST) United States $2.143B 0.00
Addus HomeCare (ADUS) United States $2.066B 22.68
Astrana Health (ASTH) United States $1.802B 36.11
U.S Physical Therapy (USPH) United States $1.078B 28.61
Pennant (PNTG) United States $0.957B 35.14
Aveanna Healthcare Holdings (AVAH) United States $0.940B 0.00
Atai Life Sciences (ATAI) Germany $0.278B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00